Pleural and Lung Cancer
10+ Years of Experience
Minimally Invasive Surgery
Board Certified in Thoracic and Cardiac Surgery
Nguyen has spent considerable time in the laboratory, heading up a research program that has been at the root of the medical school’s investigation of targeted molecular therapy for malignant pleural mesothelioma.
Making a Difference
Nguyen came to South Florida to make a difference. According to the Sylvester Cancer Center website, his translational research is designed to target “receptor-mediated signal transduction of cancer cells to achieve anti-tumor effects.”
His clinical interests include multi-modality therapy for advanced lung-cancer patients, cancer of the pleura and esophagus, minimally invasive thoracic surgery and new therapies for lung cancer.
Nguyen is affiliated with Jackson Memorial Hospital and the Miami VA Healthcare System, in addition to the cancer center, where he does the bulk of his work.
His work in Miami has been a continuation of what he started at the NIH, where he was part of a research group that helped determine the feasibility of targeting a particular pathway for molecular intervention in the cells of patients with pleural mesothelioma.
Get the Best Treatment
Get help connecting with Dr. Nguyen and find the treatment that's best for you.Get Help Now
Before he left the NIH, Nguyen participated in research published by the American Journal of Respiratory and Critical Care Medicine that linked particular lung cysts with genetics.
Nguyen began his medical career in Canada, where he finished his schooling at McGill University in Montreal in 1986. He did his surgical and cardiothoracic residencies at McGill, and later returned briefly as a staff surgeon before joining the NIH in Bethesda, Maryland.
In Miami, he was part of a research group that published a study that examined socioeconomic and racial disparities that existed in lung cancer treatment. It concluded that the median survival time after diagnosis was shorter for African American patients primarily because of a lack of pre-treatment performance.
Nguyen is part of a Molecular Oncology and Experimental Therapies program at Sylvester, where the goal is to develop and implement treatments to increase cure rates for cancer patients. He also expects to be taking an increasingly larger role with mesothelioma patients with the VA system in South Florida, where he serves as a thoracic surgeon.See More Top Mesothelioma Doctors
Disclaimer: Dr. Dao Nguyen has no professional affiliation with Asbestos.com.
Share this article
Last Modified October 17, 2018
3 Cited Article Sources
- Stewart, J.H., IV, Nguyen, D.M., Chen, G.A. & Schrump, D.S. (2002). Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway. Journal of Thoracic and Cardiovascular Surgery, 123, 295-302. doi: 10.1067/mtc.2002.11988
- Toro, J. R., Pautler, S.E., Stewart, L., Glenn, G. M., Weinreich M., Toure, O. Ming-Hui Wei, . . . Linehan, W. M. (2007, February 22). Lung Cysts, Spontaneous Pneumothorax, and Genetic Associations in 89 Families with Birt-Hogg-Dubé Syndrome. American Journal of Respiratory and Critical Care Medicine, 175, 1044-1053.doi:10.1164/rccm.200610-1483OC
- Yang, R., MD, Cheung, M.C., MD, Byrne, M.M., Huang,Y., MD, Nguyen, D., MD; Lally, B.E., MD, & Koniaris, L.G., MD. (2010, March 5). Do Racial or Socioeconomic Disparities Exist in Lung Cancer Treatment? Cancer, 116, 2437-2447. doi: 10.1002/cncr.24986